Inscripta Raises $125M in Series D Financing to Accelerate Commercialization of Revolutionary Digital Genome Engineering Platform

New Funding Brings Total Amount Raised by the Company to $259.5 Million Inscripta, Inc., today announced the company has raised $125 million in a Series D financing with support from the company’s exi...

Learn More

AVITA Medical Teams With Gates Center to Advance Therapeutic Skin Restoration

AVITA Medical (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, and scientists at the...

Learn More

Bond Pet Foods Completes $1.2 Million Seed Funding Round

BOULDER, Colo., Dec. 4, 2019 /PRNewswire/ -- Bond Pet Foods, Inc., the Boulder-based company working with biotechnology to make nutritious, animal-free and protein-rich pet food, a...

Learn More

ArcherDX Announces Partnership with Illumina to Develop In-Vitro Diagnostic Tests

Partnership Expands Physician Access to Clinical Testing that May be Performed in Local Laboratories for Solid Tumor Cancers, Hematological Malignancies and Minimal Residual Disease Monitoring BOULDER...

Learn More

$5.2 Million Advanced Industries Awards in Fall 2019 Will Fuel 24 Colorado Start-ups

A Colorado company with the transformative technology behind a revolutionary prosthetic socket design that provides easier application and release was among 24 Colorado start-ups approved for funding...

Learn More

Securisyn Medical Awarded Fourth Air Force Contract for Innovation

HIGHLANDS RANCH – November 12, 2019 – Securisyn Medical, LLC, dedicated to inspiring the world to collaborate to make airway management safer, announced today that the United States Air Force (US...

Learn More

AMPIO PROVIDES UPDATE ON CONTINUED PROGRESS OF AP-013 PHASE III CLINICAL TRIAL AND MANUFACTURING FACILITY

ENGLEWOOD, Colo., October 10, 2019, /PRNewswire/ — Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) a development stage biopharmaceutical company, executing a Special Protocol Assessment (S...

Learn More

Biodesix Appoints Scott Hutton as Chief Executive Officer

Former CEO David Brunel to Serve as Chairman of the Board of Directors BOULDER, Colo., November 4, 2019 -- Biodesix, Inc., the leader in lung cancer diagnostic solutions, today announced tha...

Learn More

IM Therapeutics Is Developing A Novel Targeted Therapy Pipeline in Autoimmune Disease

Type 1 Diabetes Therapy Being Readied for Clinical Trials; Celiac Disease in Drug Development Autoimmune diseases affect about 4% of the world’s population and comprise over 80 disorders, many of whic...

Learn More

SomaLogic significantly expands key strategic collaboration with Novartis

Ten-year agreement with Novartis demonstrates broad and deep commitment to accelerating disease and therapeutic-specific insights based on proprietary proteomic technology Boulder, Colo., USA — SomaLo...

Learn More